TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.050
+0.450 (12.50%)
At close: Dec 20, 2024, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Dec 20, 2024, 6:43 PM EST
TriSalus Life Sciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for TLSI stock have an average target of 11.75, with a low estimate of 10 and a high estimate of 16. The average target predicts an increase of 190.12% from the current stock price of 4.05.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TLSI stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 1 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 4 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $10 | Buy | Initiates | $10 | +146.91% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +171.60% | Nov 15, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +171.60% | Nov 11, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates $13 | Buy | Initiates | $13 | +208.64% | Oct 25, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +146.91% | Sep 16, 2024 |
Financial Forecast
Revenue This Year
29.80M
from 18.51M
Increased by 60.97%
Revenue Next Year
45.79M
from 29.80M
Increased by 53.69%
EPS This Year
-1.29
from -6.73
EPS Next Year
-0.52
from -1.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 31.2M | 50.7M | 88.8M | |||
| Avg | 29.8M | 45.8M | 69.8M | |||
| Low | 28.0M | 42.1M | 59.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 68.3% | 70.2% | 93.9% | |||
| Avg | 61.0% | 53.7% | 52.5% | |||
| Low | 51.3% | 41.4% | 28.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.20 | -0.20 | 0.70 |
| Avg | -1.29 | -0.52 | -0.26 |
| Low | -1.37 | -0.98 | -0.80 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.